Patent · US Active

Inhibitors of RAF kinases

US11377431B2 · kind B2 · utility

5Cited by
4References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 11, 2021
Grant dateJul 5, 2022
Priority date—
Expiry dateOct 11, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.